Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MYOMO, INC.MYO · Entity 7135 | Chief Medical Officer | September 11, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MYOMO, INC.
Report date September 11, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,245 |
Reported balance
After 2026-09-11 transaction · row 1
1 source rowRow 1 · 2026-09-11 · Sale · Disposed 15,488 · Balance 90,245 F1: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2023 Filed Apr 3, 2023 22:01 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 129 | $0.73 | $94.17 |
DisclosureSEC source: 0001209191-23-022342 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,188 F1 · shares: Represents shares sold on April 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on April 2, 2023. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 23:53 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017968 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,317 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in their entirety on March 8, 2024. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:34 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 130 | $0.62 | $80.60 |
DisclosureSEC source: 0001209191-23-016286 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,317 F1 · shares: Represents shares sold on March 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on March 2, 2023. Read SEC document |
| February 03, 2023 Filed Feb 3, 2023 22:07 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 132 | $0.49 | $64.68 |
DisclosureSEC source: 0001209191-23-007024 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,447 F1 · shares: Represents shares sold on February 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on February 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 00:08 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 139 | $0.49 | $68.11 |
DisclosureSEC source: 0001209191-23-001387 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,579 F1 · shares: Represents shares sold on January 4, 2023 solely to pay income taxes resulting from vesting of restricted stock units on January 2, 2023. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 22:44 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 126 | $0.66 | $83.16 |
DisclosureSEC source: 0001209191-22-059803 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,718 F1 · shares: Represents shares sold on December 5, 2022 solely to pay income taxes resulting from vesting of restricted stock units on December 2, 2022. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 21:28 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 125 | $1.37 | $171.25 |
DisclosureSEC source: 0001209191-22-055833 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,844 F1 · shares: Represents shares sold on November 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on November 2, 2022. Read SEC document |
| October 03, 2022 Filed Oct 3, 2022 20:37 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 128 | $1.57 | $200.96 |
DisclosureSEC source: 0001209191-22-051849 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,969 F1 · shares: Represents shares sold on October 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on October 2, 2022. Read SEC document |
| September 06, 2022 Filed Sep 6, 2022 20:36 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 128 | $1.76 | $225.28 |
DisclosureSEC source: 0001209191-22-048761 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,097 F1 · shares: Represents shares sold on September 6, 2022 solely to pay income taxes resulting from vesting of restricted stock units on September 2, 2022. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:25 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 118 | $1.91 | $225.55 |
DisclosureSEC source: 0001209191-22-044423 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,225 F1 · shares: Represents shares sold on August 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on August 2, 2022. Read SEC document |
| July 05, 2022 Filed Jul 5, 2022 20:57 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 127 | $1.64 | $208.28 |
DisclosureSEC source: 0001209191-22-040760 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,343 F1 · shares: Represents shares sold on July 5, 2022 solely to pay income taxes resulting from vesting of restricted stock units on July 2, 2022. Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 13:20 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 484 | $1.83 | $885.72 |
DisclosureSEC source: 0001209191-22-037262 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,470 F1 · shares: Represents shares sold on June 13, 2022 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2022. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:49 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035945 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,954 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 8, 2023. Read SEC document |
| June 03, 2022 Filed Jun 3, 2022 23:20 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 138 | $2.31 | $318.78 |
DisclosureSEC source: 0001209191-22-034354 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,954 F1 · shares: Represents shares sold on June 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on June 2, 2022. Read SEC document |
| May 24, 2022 Filed May 24, 2022 22:15 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 2,849 | $2.06 | $5,868.94 |
DisclosureSEC source: 0001209191-22-031711 · doc4.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,092 F2 · shares: Represents shares sold on May 24, 2022 solely to pay income taxes resulting from vesting of restricted stock units on May 20, 2022. Read SEC document |
| May 20, 2022 Filed May 24, 2022 22:15 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 6,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031711 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,941 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| May 03, 2022 Filed May 3, 2022 20:27 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 134 | $3.03 | $406.02 |
DisclosureSEC source: 0001209191-22-026720 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,954 F1 · shares: Represents shares sold on May 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on May 2, 2022. Read SEC document |
| April 04, 2022 Filed Apr 4, 2022 22:44 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 134 | $4.01 | $537.34 |
DisclosureSEC source: 0001209191-22-022670 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,088 F1 · shares: Represents shares sold on April 4, 2022 solely to pay income taxes resulting from vesting of restricted stock units on April 2, 2022. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 00:52 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 131 | $7.22 | $945.82 |
DisclosureSEC source: 0001209191-22-017332 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,222 F1 · shares: Represents shares sold on March 7, 2022 solely to pay income taxes resulting from vesting of restricted stock units on March 2, 2022. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 23:15 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 132 | $7.60 | $1,003.20 |
DisclosureSEC source: 0001209191-22-007308 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,353 F1 · shares: Represents shares sold on February 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on February 2, 2022. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 23:17 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 125 | $7.22 | $902.50 |
DisclosureSEC source: 0001209191-22-001143 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,485 F1 · shares: Represents shares sold on January 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on January 2, 2022. Read SEC document |
| December 03, 2021 Filed Dec 3, 2021 22:36 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 128 | $7.75 | $992.00 |
DisclosureSEC source: 0001209191-21-067936 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,610 F1 · shares: Represents shares sold on December 3, 2021 solely to pay income taxes resulting from vesting of restricted stock units on December 2, 2021. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 21:20 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 1,625 | $10.39 | $16,883.75 |
DisclosureSEC source: 0001209191-21-062972 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,738 F1 · shares: Represents shares sold on November 3, 2021 solely to pay income taxes resulting from vesting of restricted stock units on November 2, 2021. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:11 UTC | MYOMO, INC. MYO · Entity 7135 | GrantRestricted Stock Units · Derivative | 8,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039814 · doc4.xml · derivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 8,200 shares Expires not disclosed F2 · shares: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. F2 · derivative.expiration_date: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:11 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 4,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039814 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,363 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 9, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.